Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers.
Sato, Yuki
Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers. [electronic resource] - Journal of atherosclerosis and thrombosis Feb 2007 - 31-5 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1340-3478
10.5551/jat.14.31 doi
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--therapeutic use
Aged
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Benzimidazoles--therapeutic use
Biphenyl Compounds
Cardiovascular Diseases--prevention & control
Female
Humans
Hypertension--blood
Light
Losartan--therapeutic use
Male
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors
Platelet Function Tests
Scattering, Radiation
Tetrazoles--therapeutic use
Therapeutic Equivalency
Platelet aggregability in patients with hypertension treated with angiotensin II type 1 receptor blockers. [electronic resource] - Journal of atherosclerosis and thrombosis Feb 2007 - 31-5 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1340-3478
10.5551/jat.14.31 doi
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--therapeutic use
Aged
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Benzimidazoles--therapeutic use
Biphenyl Compounds
Cardiovascular Diseases--prevention & control
Female
Humans
Hypertension--blood
Light
Losartan--therapeutic use
Male
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors
Platelet Function Tests
Scattering, Radiation
Tetrazoles--therapeutic use
Therapeutic Equivalency